Report Content

Chapter 1   Methodology

1.1    Definition and forecast parameters

1.1.1    Definition

1.1.2    Methodology and forecast parameters

1.2    Data sources

1.3    References & sources

1.3.1    Secondary

1.3.2    Primary

Chapter 2   Executive Summary

2.1    Asia Pacific imaging agents industry summary, 2017 – 2028

2.1.1    Business trends

2.1.2    Product type trends

2.1.3    Application trends

2.1.4    Modality trends

2.1.5    End-use trends

2.1.6    Country trends

Chapter 3   Industry Insights

3.1    Industry segmentation

3.2    Industry outlook, 2017 – 2028

3.3    Major factor analysis

3.3.1    Growth drivers

3.3.1.1   Rapidly growing cancer and CVD population across the Asia Pacific region

3.3.1.2   Surging innovation in imaging procedures and agents

3.3.1.3   Rising demand for image-guided procedures

3.3.1.4   Increasing healthcare expenditure

3.3.2    Restraints & challenges

3.3.2.1   High costs of imaging agents and procedures

3.3.2.2   Side effects associated with the imaging agents and diagnostic imaging procedures

3.4    COVID-19 impact analysis

3.5    Porter’s analysis

3.6    Competitive review, 2021

3.7    PEST analysis

Chapter 4   Asia Pacific Imaging Agents Market, By Product Type

4.1    Key trends in Asia Pacific imaging agents market estimates and forecast, by product type

4.2    Iodinated contrast media

4.2.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

4.3    Gadolinium-based contrast media

4.3.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

4.4    Microbubble contrast media

4.4.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

4.5    Barium-based contrast media

4.5.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

Chapter 5   Asia Pacific Imaging Agents Market, By Application

5.1    Key segment trends in Asia Pacific imaging agents market estimates and forecast, by application

5.2    Oncology

5.2.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

5.3    Cardiology

5.3.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

5.4    Gastrointestinal

5.4.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

5.5    Neurology

5.5.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

5.6    Others

5.6.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

Chapter 6   Asia Pacific Imaging Agents Market, By Modality

6.1    Key segment trends in Asia Pacific imaging agents market estimates and forecast, by modality

6.2    X-Ray

6.2.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

6.3    Computed Tomography (CT)

6.3.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

6.4    Magnetic Resonance Imaging (MRI)

6.4.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

6.5    Ultrasound

6.5.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

6.6    Others

6.6.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

Chapter 7   Asia Pacific Imaging Agents Market, By End-use

7.1    Key segment trends in Asia Pacific imaging agents market estimates and forecast, by end-use

7.2    Hospitals

7.2.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

7.3    Ambulatory Surgical Centers

7.3.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

7.4    Diagnostic & Imaging Centers

7.4.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

7.5    Others

7.5.1    Market estimates and forecast, by country, 2017 -2028 (USD Million)

Chapter 8   Asia Pacific Imaging Agents Market, By Country

8.1    Key trends in Asia Pacific imaging agents market estimates and forecast, by country

8.2    Japan

8.2.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

8.2.2    Market estimates and forecast, by application, 2017-2028 (USD Million)

8.2.3    Market estimates and forecast, by modality, 2017-2028 (USD Million)

8.2.4    Market estimates and forecast, by end-use, 2017-2028 (USD Million)

8.3    China

8.3.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

8.3.2    Market estimates and forecast, by application, 2017-2028 (USD Million)

8.3.3    Market estimates and forecast, by modality, 2017-2028 (USD Million)

8.3.4    Market estimates and forecast, by end-use, 2017-2028 (USD Million)

8.4    India

8.4.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

8.4.2    Market estimates and forecast, by application, 2017-2028 (USD Million)

8.4.3    Market estimates and forecast, by modality, 2017-2028 (USD Million)

8.4.4    Market estimates and forecast, by end-use, 2017-2028 (USD Million)

8.5    Australia

8.5.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

8.5.2    Market estimates and forecast, by application, 2017-2028 (USD Million)

8.5.3    Market estimates and forecast, by modality, 2017-2028 (USD Million)

8.5.4    Market estimates and forecast, by end-use, 2017-2028 (USD Million)

8.6    South Korea

8.6.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

8.6.2    Market estimates and forecast, by application, 2017-2028 (USD Million)

8.6.3    Market estimates and forecast, by modality, 2017-2028 (USD Million)

8.6.4    Market estimates and forecast, by end-use, 2017-2028 (USD Million)

8.7    Taiwan

8.7.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

8.7.2    Market estimates and forecast, by application, 2017-2028 (USD Million)

8.7.3    Market estimates and forecast, by modality, 2017-2028 (USD Million)

8.7.4    Market estimates and forecast, by end-use, 2017-2028 (USD Million)

8.8    Indonesia

8.8.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

8.8.2    Market estimates and forecast, by application, 2017-2028 (USD Million)

8.8.3    Market estimates and forecast, by modality, 2017-2028 (USD Million)

8.8.4    Market estimates and forecast, by end-use, 2017-2028 (USD Million)

8.9    Malaysia

8.9.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

8.9.2    Market estimates and forecast, by application, 2017-2028 (USD Million)

8.9.3    Market estimates and forecast, by modality, 2017-2028 (USD Million)

8.9.4    Market estimates and forecast, by end-use, 2017-2028 (USD Million)

8.10    Thailand

8.10.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

8.10.2    Market estimates and forecast, by application, 2017-2028 (USD Million)

8.10.3    Market estimates and forecast, by modality, 2017-2028 (USD Million)

8.10.4    Market estimates and forecast, by end-use, 2017-2028 (USD Million)

Chapter 9   Company Profiles

9.1    Bayer Healthcare Pharmaceuticals

9.1.1    Business overview

9.1.2    Financial data

9.1.3    Product landscape

9.1.4    Strategic outlook

9.2    Beijing Beilu Pharmaceutical

9.2.1    Business overview

9.2.2    Financial data

9.2.3    Product landscape

9.3    Bracco Diagnostics, Inc.

9.3.1    Business overview

9.3.2    Financial data

9.3.3    Product landscape

9.3.4    Strategic outlook

9.4    Eli Lilly & Company

9.4.1    Business overview

9.4.2    Financial data

9.4.3    Product landscape

9.4.4    Strategic outlook

9.5    GE Healthcare

9.5.1    Business overview

9.5.2    Financial data

9.5.3    Product landscape

9.5.4    Strategic outlook

9.6    Guerbet Group

9.6.1    Business overview

9.6.2    Financial data

9.6.3    Product landscape

9.6.4    Strategic outlook

9.7    Trivitron Healthcare

9.7.1    Business overview

9.7.2    Financial data

9.7.3    Product landscape

9.7.4    Strategic outlook